![Kinnate Biopharma Inc. logo](/logos/KNTE.webp)
Kinnate Biopharma Inc.
NASDAQ:KNTE
Overview | Financials
Company Name | Kinnate Biopharma Inc. |
Symbol | KNTE |
Currency | USD |
Price | 2.65 |
Market Cap | 124,990,960 |
Dividend Yield | 0% |
52-week-range | 1.04 - 7.185 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Nima Farzan M.B.A. |
Website | https://www.kinnate.com |
An error occurred while fetching data.
About Kinnate Biopharma Inc.
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD